INTS
USDIntensity Therapeutics Inc. Common stock
$0.566-0.084 (-12.954%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Key Metrics
Market Metrics
Open
$0.650
High
$0.650
Low
$0.550
Volume
0.00M
Company Fundamentals
Market Cap
13.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.10M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.55Current $0.566High $5.275
Related News
PR Newswire
Intensity Therapeutics Reports 2024 Year End Financial Results and Provides Corporate Update
Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.